Scope of the Study
The transseptal needle is a uniquely designed needle to assist the physician in gaining access to the left atrium by using radiofrequency energy in a controlled manner as opposed to mechanical force. It is used in the procedure transseptal puncture. It is a frequently performed procedure for gaining access to the left catheter ablation, hemodynamic assessment of the left heart, left ventricular assist device implantation, percutaneous left atrial appendage closure or mitral valvuloplasty during childhood and adulthood.
The market study is being classified, by Application (Atrial fibrillation (AF) ablation, Left atrial appendage (LAA) occlusion and Mitral valve repair) and major geographies with country level break-up.
Cook Medical (United States), Medtronic plc (Ireland), AngioDynamics, Inc. (United States), Biolitec AG (Germany), Syneron Medical Ltd (United States), Lumenis Ltd (Israel), Covidien (United States), Boston Scientific Corporation (United States), BSD Medical (United States) and Misonix Inc. (United States) are some of the key players profiled in the study.
Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Transseptal Needle market throughout the predicted period.
AdvanceMarketAnalytics has segmented the market of Global Transseptal Needle market by Type, Application and Region.
On the basis of geography, the market of Transseptal Needle has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Increased Number of Surgical Procedures around the Globe
- Rising Prevalence of Heart Diseases
- Increased Number of New Hospitals and Diagnostic Centres
- Changing Lifestyle of the People
- Risk Associated with these Procedures
- Growth in the Healthcare Industry
- Rise in the Distribution Channels
- Growing Healthcare Infrastrue in Developing Regions
- Stringent Rules and Regulations
Market Leaders and their expansionary development strategies
In November 2019, Baring Private Equity Asia has announced that its affiliated private equity funds ("BPEA") have agreed to acquire Lumenis, a leading provider of specialty energy-based medical devices across the fields of aesthetics, urology, ophthalmology, ENT and gynecology from XIO.
Key Target AudienceTransseptal Needle Manufacturers, Raw Material Prices, Distributors, Government Bodies and End-users
Customization in the Report Available:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase